Related Experiment Video
Updated: Jan 18, 2026

Systematic Hearing Performance Evaluation Process for Adolescents with Cochlear Implantation at Early Ages
Published on: March 24, 2023
Twenty-five years later: has ISBT 128 fulfilled its promise?
1International Council for Commonality in Blood Bank Automation, Redlands, California.
The ISBT 128 standard provides global traceability for medical products of human origin (MPHO). This review examines its 25-year development, current use, and future potential for improving data accuracy and hemovigilance.
Area of Science:
- Medical Science
- Biotechnology
- Health Informatics
Background:
- Traceability is crucial for quality assurance in medical products of human origin (MPHO).
- Standardized systems are needed for accurate data collection and electronic readability.
- The ISBT 128 standard has been the global benchmark for MPHO labeling for 25 years.
Purpose of the Study:
- To review the historical development of the ISBT 128 Standard.
- To assess the current status and global adoption of ISBT 128.
- To explore potential future applications and advancements of the ISBT 128 Standard.
Main Methods:
- Literature review of ISBT 128 specifications and related publications.
- Analysis of ISBT 128's impact on MPHO traceability and data management.
- Examination of case studies and industry adoption trends.
Main Results:
- ISBT 128 has become the international standard for MPHO labeling and information transfer.
- Standardized coding enhances hemovigilance and aggregated data activities.
- The system has improved accuracy and efficiency in data collection.
Conclusions:
- The ISBT 128 Standard has significantly advanced MPHO traceability and quality.
- Continued development and adoption of ISBT 128 are vital for future healthcare innovations.
- The standard's adaptability supports evolving needs in medical product management.
More Related Videos
07:31A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills
Published on: February 13, 2020
09:30Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
Published on: August 17, 2022
Related Concept Videos
Quality Assurance
Drug Product Stability
SBAR II: Application of SBAR
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...